http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 November 12, 2009 - Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and... http://pharmalicensing.com/redirs/news_rss//public/news/view/499900/2/0/champions-biotechnology-to-present-data-at-aacr-eortc-2009-regarding-the-predictability-of-biomerk-tumorgraft-tm-platform-to-guide-personalized-cancer-treatment-and-accelerate-oncology-drug-development http://pharmalicensing.com/redirs/news_rss//public/news/view/499900/2/0/champions-biotechnology-to-present-data-at-aacr-eortc-2009-regarding-the-predictability-of-biomerk-tumorgraft-tm-platform-to-guide-personalized-cancer-treatment-and-accelerate-oncology-drug-development Basel, November 12, 2009 - Novartis announced the availability of Prevacid http://pharmalicensing.com/redirs/news_rss//public/news/view/499908/2/0/novartis-launches-prevacid http://pharmalicensing.com/redirs/news_rss//public/news/view/499908/2/0/novartis-launches-prevacid Princeton, NJ and San Diego, CA, November 12, 2009--Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening... http://pharmalicensing.com/redirs/news_rss//public/news/view/499708/2/0/tobira-therapeutics-inc-announce-presentation-of-tbr-652-data-at-european-aids-conference http://pharmalicensing.com/redirs/news_rss//public/news/view/499708/2/0/tobira-therapeutics-inc-announce-presentation-of-tbr-652-data-at-european-aids-conference Montr http://pharmalicensing.com/redirs/news_rss//public/news/view/499756/2/0/theratechnologies-presents-combined-phase-3-clinical-results-at-european-aids-conference http://pharmalicensing.com/redirs/news_rss//public/news/view/499756/2/0/theratechnologies-presents-combined-phase-3-clinical-results-at-european-aids-conference NORWALK, CT, November 11, 2009 - IMS Health (NYSE: RX), the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the upcoming launch of IMS... http://pharmalicensing.com/redirs/news_rss//public/news/view/499769/2/0/ims-health-to-launch-oncology-quantifier-delivering-integrated-insights-for-enhanced-market-measurement-commercial-strategies http://pharmalicensing.com/redirs/news_rss//public/news/view/499769/2/0/ims-health-to-launch-oncology-quantifier-delivering-integrated-insights-for-enhanced-market-measurement-commercial-strategies New York and Petach Tikvah, Israel - November 11, 2009 - BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce... http://pharmalicensing.com/redirs/news_rss//public/news/view/499771/2/0/brainstorm-chief-medical-advisor-interviewed-on-israel-radio-broadcast-states-stem-cell-therapy-treatment-ready-for-clinical-trials http://pharmalicensing.com/redirs/news_rss//public/news/view/499771/2/0/brainstorm-chief-medical-advisor-interviewed-on-israel-radio-broadcast-states-stem-cell-therapy-treatment-ready-for-clinical-trials MENLO PARK, Calif., November 11, 2009 - Geron Corporation (Nasdaq: GERN) today announced the publication of data showing that oligodendrocyte progenitor cells (OPCs) derived from human embryonic stem... http://pharmalicensing.com/redirs/news_rss//public/news/view/499783/2/0/geron-collaborators-publish-data-on-hesc-derived-glial-progenitor-cell-therapy-in-cervical-spinal-cord-injury http://pharmalicensing.com/redirs/news_rss//public/news/view/499783/2/0/geron-collaborators-publish-data-on-hesc-derived-glial-progenitor-cell-therapy-in-cervical-spinal-cord-injury Amsterdam, The Netherlands - November 11, 2009 - Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that it has successfully treated... http://pharmalicensing.com/redirs/news_rss//public/news/view/499801/2/0/amt-successful-in-preclinical-treatment-of-dmd http://pharmalicensing.com/redirs/news_rss//public/news/view/499801/2/0/amt-successful-in-preclinical-treatment-of-dmd SANTA ANA, Calif., November 11, 2009 -- Capario, a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, today announced a new release of its... http://pharmalicensing.com/redirs/news_rss//public/news/view/499705/2/0/capario-launches-updated-version-of-its-revenue-cycle-management-portal-for-providers http://pharmalicensing.com/redirs/news_rss//public/news/view/499705/2/0/capario-launches-updated-version-of-its-revenue-cycle-management-portal-for-providers November 11, 2009--A recent paper, by researchers at Genentech, describes the preclinical evaluation of the pharmacokinetic properties of GDC-0449, a potent selective Hedgehog signalling pathway... http://pharmalicensing.com/redirs/news_rss//public/news/view/499713/2/0/simcyp-simulator-aids-in-preclinical-adme-assessment-of-genentech-compound http://pharmalicensing.com/redirs/news_rss//public/news/view/499713/2/0/simcyp-simulator-aids-in-preclinical-adme-assessment-of-genentech-compound